Patent details

300407 Product Name: Tafluprost, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300407
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0850926
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300407
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

1

Marketing Authorization Number:
43230
Marketing Authorization Type:
EEA
Marketing Authorization Date:
30/04/2008
Marketing Authorization Country:
Denmark (DK)

2

Marketing Authorization Number:
RVG 103823
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
03/04/2009
Marketing Authorization Country:
Netherlands (NL)

Dates

Filing date:
02/09/2009
First Marketing Authorization date:
30/04/2008
Grant date:
17/12/2009
Activation date:
22/12/2017
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
02/09/2009
SPC/SPC Extension Expiration Date:
21/12/2022
Lapsed By Expiration Date:
22/12/2022
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
15/08/2018
 
 

 

Name:
AGC Inc.
Address:
1-5-1 Marunouchi Chiyoda-ku, 100-8405, Tokyo, Japan (JP)

From:
15/08/2018
 
 

 

Name:
SANTEN PHARMACEUTICAL CO., LTD.
Address:
9-19, Shimoshinjo 3-chome, HIGASHIYODOGAWA-KU, OSAKA-SHI, OSAKA 533-8651, Japan (JP)

Historical Applicant/holder

From:
02/09/2009
To:
15/08/2018

 

Name:
ASAHI GLASS COMPANY LTD.
Address:
1-12-1, Yurakucho 1-chome Chiyoda-ku, 100-8405, Tokyo, Japan (JP)

From:
02/09/2009
To:
15/08/2018

 

Name:
SANTEN PHARMACEUTICAL CO., LTD.
Address:
9-19, Shimoshinjo 3-chome Higashiyodogawa-ku, 533, Osaka-shi, Osaka, Japan (JP)

Agent

Name:
ir. A. Blokland c.s.
From:
02/09/2009
Address:
Algemeen Octrooi- en Merkenbureau B.V. Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
51/22
Publication date:
21/12/2022
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
43/18
Publication date:
17/10/2018
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
SPC
Journal edition number:
52/17
Publication date:
28/12/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
SPC
Journal edition number:
2010/03
Publication date:
01/03/2010
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
2009/11
Publication date:
02/11/2009
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of Legal Entity
Deed Number:
RC201801463B
Date Registered:
15/08/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. A. Blokland c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
SANTEN PHARMACEUTICAL CO., LTD.
Address:
9-19, Shimoshinjo 3-chome, HIGASHIYODOGAWA-KU, OSAKA-SHI, OSAKA 533-8651, Japan (JP)

2

Name:
AGC Inc.
Address:
1-5-1 Marunouchi Chiyoda-ku, 100-8405, Tokyo, Japan (JP)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
10/12/2021
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
17/12/2009 SPC Documents Certificate SPC 1 PDF /7/0/4/0/0/0400300407/docs/300407_0_supplprotectioncertificate20210218114103000.pdf
17/12/2009 Outgoing Correspondence Outgoing Letter 1 PDF /7/0/4/0/0/0400300407/docs/300407_11_outgoingcorrespondence20210218113829079.pdf
04/12/2009 SPC Documents Marketing Authorization SPC 3 PDF /7/0/4/0/0/0400300407/docs/300407_2_supplprotectioncertificate20210218112346458.pdf
04/12/2009 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /7/0/4/0/0/0400300407/docs/300407_4_incomingcorrespondencepaper20091204.pdf
04/12/2009 SPC Documents Summary of the characteristics of the product 7 PDF /7/0/4/0/0/0400300407/docs/300407_5_supplprotectioncertificate20210218112346527.pdf
24/11/2009 Outgoing Correspondence Outgoing Letter 1 PDF /7/0/4/0/0/0400300407/docs/300407_1_outgoingcorrespondence20091124.pdf
23/10/2009 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /7/0/4/0/0/0400300407/docs/300407_6_incomingcorrespondencepaper20210218111745377.pdf
23/10/2009 SPC Documents Annex SPC 2 PDF /7/0/4/0/0/0400300407/docs/300407_7_supplprotectioncertificate20210218111901407.pdf
03/09/2009 Outgoing Correspondence Outgoing Letter 1 PDF /7/0/4/0/0/0400300407/docs/300407_3_outgoingcorrespondence20090903.pdf
02/09/2009 SPC Documents Marketing Authorization SPC 1 PDF /7/0/4/0/0/0400300407/docs/300407_8_supplprotectioncertificate20210218111108718.pdf
02/09/2009 SPC Documents Accompanying letter SPC 2 PDF /7/0/4/0/0/0400300407/docs/300407_9_supplprotectioncertificate20210218111543190.pdf
02/09/2009 SPC Documents SPC Documents 7 PDF /7/0/4/0/0/0400300407/docs/300407_10_supplprotectioncertificate20210218111244848.pdf
02/09/2009 Application Form First filed application form 2 PDF /7/0/4/0/0/0400300407/docs/300407_12_applicationform20090902.pdf